Back to Search
ALEX D'AMICO, M.D.
M.D.
Student in an Organized Health Care Education/Training Program
NPI: 1326626524Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease.
PMID 19597029·J Clin Oncol·2009
8-other
Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death.
PMID 19395184·Int J Radiat Oncol Biol Phys·2009
4-observational
p53 protein expression status and recurrence in men treated with radiation and androgen suppression therapy for higher-risk prostate cancer: a prospective phase II Cancer and Leukemia Group B Study (CALGB 9682).
PMID 18291508·Urology·2008
3-trial
Tumor volume changes on 1.5 tesla endorectal MRI during neoadjuvant androgen suppression therapy for higher-risk prostate cancer and recurrence in men treated using radiation therapy results of the phase II CALGB 9682 study.
PMID 18037582·Int J Radiat Oncol Biol Phys·2008
3-trial
Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer.
PMID 18980297·Cancer·2008
8-other
Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial.
PMID 18212313·JAMA·2008
4-observational
Heart transplantation in a child with LGMD2I presenting as isolated dilated cardiomyopathy.
PMID 18060779·Neuromuscul Disord·2008
5-case
Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy.
PMID 18565884·J Clin Oncol·2008
2-rct
Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate.
PMID 17397033·Cancer·2007
4-observational
Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors.
PMID 17530618·Cancer·2007
8-other
Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.
PMID 17557956·J Clin Oncol·2007
8-other
Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality.
PMID 17315162·Cancer·2007
8-other
Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.
PMID 17229162·BJU Int·2007
6-review
Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy.
PMID 17828774·Cancer·2007
8-other
Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.
PMID 17196507·Lancet Oncol·2007
4-observational
Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.
PMID 17084157·J Urol·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 625 19TH ST S
BIRMINGHAM, AL 35233 - Phone
- (205) 789-1360
Quick Facts
- NPI
- 1326626524
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile